Avidity Biosciences, Inc.
NASDAQ:RNA
30.11 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Avidity Biosciences, Inc. |
Symbool | RNA |
Munteenheid | USD |
Prijs | 30.11 |
Beurswaarde | 3,592,393,990 |
Dividendpercentage | 0% |
52-weken bereik | 8.86 - 56 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Sarah Boyce |
Website | https://www.aviditybiosciences.com |
An error occurred while fetching data.
Over Avidity Biosciences, Inc.
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)